CorMedix (CRMD) Long-Term Investments (2024 - 2025)
CorMedix's (CRMD) quarterly Long-Term Investments came in at $23.8 million in Q4 2025, up 22581.9% year-on-year from N/an in Q4 2024, and up 3.94% quarter-over-quarter from $22.9 million in Q3 2025.
CorMedix (CRMD) Long-Term Investments (2024 - 2025) Analysis & Trends
CorMedix has disclosed Long-Term Investments across 2 years of filings, most recently posting $23.8 million for Q4 2025.
- Long-Term Investments for Q4 2025 came in at $23.8 million, up 22581.9% year-over-year; the trailing twelve-month figure through Dec 2025 was $23.8 million (up 22581.9% YoY), and the FY2025 annual result was $23.8 million, up 22581.9% from the prior year.
- Long-Term Investments came in at $23.8 million for Q4 2025 at CorMedix, up from $22.9 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $23.8 million in Q4 2025 to a low of $105000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | CorMedix | 631,378.03 | -154.57 Mn | 107.31 Mn | 23.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23.82 Mn |
| Sep 30, 2025 | 22.91 Mn |
| Dec 31, 2024 | 105,000.00 |